DHR
Danaher Corporation$204.73
Sell
Target $178.71
Report: Mar 13, 2026Healthcare • Medical - Diagnostics & Research • Mature CompounderSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$204.73-12.7%
Rec: SellConviction: High
Entry Target
N/A
N/A
Fair Value
$178.71
(13% below current)
Stop Loss
N/A
N/A
Position Size
None
Time Horizon
N/A
Key Metrics
Live Snapshot
Market Data
52 Week High$242.80
52 Week Low$171.00
Avg. 3 Month Volume4.06M
Efficiency
LTM Gross Margin59.1%
LTM EBITDA Margin28.3%
LTM EBIT Margin18.4%
LTM Operating Margin19.1%
LTM ROA4.5%
LTM ROE7.0%
LTM ROIC16.2%
LTM ROCE6.1%
Capital Structure
Market Cap (MM)$134.1B
Enterprise Value (MM)$147.9B
Shares Outstanding707.30M
Total Debt (MM)$18.42B
Cash & Equivalents (MM)$4.62B
LTM Net Debt (MM)$13.80B
LTM Net Debt/EBITDA2.0x
Growth
TTM Rev. Growth2.9%
Last 3-Yr Rev. CAGR-7.9%
Last 3-Yr EBITDA CAGR-13.4%
Last 3-Yr EPS CAGR-19.7%
Valuation
Street Target Price$253.75
LTM EV/Revenue6.0x
LTM EV/Gross Profit10.2x
LTM EV/EBIT32.8x
LTM EV/EBITDA21.2x
LTM P/E37.1x
LTM EV/FCF27.9x
LTM P/FCF25.3x
LTM P/TB6.0x
LTM P/B2.6x
Dividend Yield0.7%
Payout Ratio25.2%
Executive SummarySituation: Current price is $204.73 versus fair value $178.71 (-12.7% expected return), and valuation confidence is stable. Debate: Bull case depends on Negative Earnings Surprise and Guidance Revision Danaher has missed EPS guidance in 60% of the last five years. Bear case centers on Moat Erosion via China VBP and Geopolitical Shifts China represents a critical growth market, but Volume-Based Procurement (VBP) is structurally lowering pricing for diagnostics. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.
Bull Case
Danaher's free cash flow conversion has exceeded 100% for 33 consecutive years, providing a massive capital base for M&A. Secular tailwinds from aging populations and the rise of GLP-1 therapies drive long-term demand for bioprocessing and diagnostics.
Bear Case
Incremental ROIC of -15.3% proves that recent M&A is value-destructive. Massive insider selling ($494.6M) and ongoing securities fraud litigation suggest management lacks confidence in the current valuation.
Key Catalysts
Mid-Term (6-18 months)Impact: High
Negative Earnings Surprise and Guidance Revision Danaher has missed EPS guidance in 60% of the last five years. A failure to meet the 3-6% c...
Mid-Term (6-18 months)Impact: Critical
Legal Developments in Hawkins v. Danaher If the ongoing securities fraud litigation moves toward a material settlement or reveals damaging i...
Long-Term (18+ months)Impact: Moderate
Danaher is at a critical juncture following the Veralto spin-off; the stock has underperformed the market by 19.3% over the last year, and t...
Primary Risks
Concern: High
Moat Erosion via China VBP and Geopolitical Shifts China represents a critical growth market, but Volume-Based Procurement (VBP) is structur...
Concern: High
Value-Destructive M&A and Reinvestment Danaher's 'Balanced Allocator' strategy is failing to generate returns above the 9.5% WACC, as eviden...
Concern: Medium
The stewardship verdict is 'Cautionary'. While the governance structure meets basic independence standards, the extreme tenure of the founde...
Recent Activity
2025-10-21SEC Filing (8-K)
+5.94%Danaher reported Q3 2025 results with net earnings of $908 million and revenue up 4.5% year-over-year.
2025-01-29SEC Filing (8-K)
-9.73%Danaher reported Q4 2024 results with $1.1B net earnings and flat full-year revenues
2024-07-23SEC Filing (8-K)
+5.30%Danaher reported Q2 2024 results with net earnings of $907 million and revenue down 3.0% year-over-year.
2024-04-23SEC Filing (8-K)
+7.21%Danaher reported Q1 2024 results with net earnings of $1.1 billion and revenue down 2.5% year-over-year.
2023-04-25SEC Filing (8-K)
-8.79%Danaher reported Q1 2023 results with net earnings of $1.4 billion and revenue down 7.0% year-over-year.
Valuation Table
9.8/10Decision Grade
Scenario Range
$120
Bear
$211
Bull
$205